Abstract
The APOE gene (apolipoprotein E) is a major risk factor for Alzheimer’s Disease (AD) but has been inconsistently associated with memory in nondemented adults. Two other genes with mixed support as genetic risk factors for AD, A2M (alpha-2-macroglobulin) and LRP (low-density lipoprotein receptor-related protein), have not been studied in relation to memory among nondemented adults. The present study examined these three genes and latent growth parameters estimated from memory performance spanning 13 years in 478 twins from the Swedish Adoption/Twin Study of Aging (SATSA). APOE was associated with working and recall memory ability levels and working memory rate of change, with e4 homozygotes exhibiting the worst performance at all ages. Homozygotes for the rare A2M insertion/deletion variant exhibited accelerating decline on delayed figural recognition. There were no significant findings for LRP. Dominance, often untested in previous studies, was important in the current study’s findings.
Similar content being viewed by others
References
Bennett D. A., Wilson R. S., Schneider J. A., Evans D. A., Mendes de Leon C. F., Arnold S. E., Barnes L. L. and Bienias J. L. (2003). Education modifies the relation of AD pathology to level of cognitive function in older persons. Neurology 60: 1909–1915
Blacker D., Wilcox M. A., Laird N. M., Rodes L., Horvath S. M., Go R.C., Perry R., Watson B. Jr., Bassett S. S., McInnis M. G., Albert M. S., Hyman B. T. and Tanzi R. E. (1998). Alpha-2 macroglobulin is genetically associated with Alzheimer disease. Nat. Genet. 19: 357–360
Bondi M. W., Salmon D. P., Galasko D., Thomas R. G. and Thal L. J. (1999). Neuropsychological function and apolipoprotein E genotype in the preclinical detection of Alzheimer’s disease. Psychol. Aging 14: 295–303
Bretsky P., Guralnik J. M., Launer L., Albert M. and Seeman T. E. (2003). The role of APOE-epsilon4 in longitudinal cognitive decline: MacArthur Studies of Successful Aging. Neurology 60: 1077–1081
Caselli R. J., Osborne D., Reiman E. M., Hentz J. G., Barbieri C. J., Saunders A. M., Hardy J., Graff-Radford N. R., Hall G. R. and Alexander G. E. (2001). Preclinical cognitive decline in late middle-aged asymptomatic apolipoprotein E-e4/4 homozygotes: a replication study. J. Neurol. Sci. 189: 93–98
Caselli R. J., Reiman E. M., Osborne D., Hentz J. G., Baxter L. C., Hernandez J. L. and Alexander G. G. (2004). Longitudinal changes in cognition and behavior in asymptomatic carriers of the APOE e4 allele. Neurology 62: 1990–1995
DeFries J. C., Plomin R., Vandenberg S. G. and Kuse A. R. (1981). Parent–offspring resemblance for cognitive abilities in the Colorado Adoption Project: Biological, adoptive, and control parents and one-year-old children. Intelligence 5: 245–277
Farrer L. A., Cupples L. A., Haines J. L., Hyman B., Kukull W. A., Mayeux R., Myers R. H., Pericak-Vance M. A., Risch N., and van Duijn C. M. (1997). Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA 278: 1349–1356
Finch C. E. and Tanzi R. E. (1997). Genetics of aging. Science 278: 407–411
Finkel D. and McGue M. (1993). The origins of individual differences in memory among the elderly: A behavior genetic analysis. Psychol. Aging 8: 527–537
Finkel D. and McGue M. (1998). Age differences in the nature and origin of individual differences in memory: a behavior genetic analysis [In Process Citation]. Int. J. Aging Hum. Dev. 47: 217–239
Flory J. D., Manuck S. B., Ferrell R. E., Ryan C. M. and Muldoon M. F. (2000). Memory performance and the apolipoprotein E polymorphism in a community sample of middle-aged adults. Am. J. Med. Genet. 96: 707–711
Fulker D. W., Cherny S. S., Sham P. C. and Hewitt J. K. (1999). Combined linkage and association sib-pair analysis for quantitative traits. Am. J. Hum. Genet. 64: 259–267
Gatz M., Pedersen N. L., Berg S., Johansson B., Johansson K., Mortimer J. A., Posner S. F., Viitanen M., Winblad B. and Ahlbom A. (1997). Heritability for Alzheimer’s disease: The study of dementia in Swedish twins. J. Gerontol. Med. Sci. 52: M117–125
Green M. S., Kaye J. A. and Ball M. J. (2000). The Oregon brain aging study: Neuropathology accompanying healthy aging in the oldest old. Neurology 54: 105–113
Johansson B., Hofer S. M., Allaire J. C., Maldonado-Molina M. M., Piccinin A. M., Berg S., Pedersen N. L. and McClearn G. E. (2004). Change in cognitive capabilities in the oldest old: the effects of proximity to death in genetically related individuals over a 6-year period. Psychol. Aging 19: 145–156
Johansson B., Whitfield K., Pedersen N. L., Hofer S. M., Ahern F. and McClearn G. E. (1999). Origins of individual differences in episodic memory in the oldest-old: a population-based study of identical and same-sex fraternal twins aged 80 and older. J. Gerontol. B Psychol. Sci. Soc. Sci. 54: P173–179
Jonsson C. -O. and Molander L. (1964). Manual till CVB-skalan [Manual of the CVB Scales]. Psykologi Förlaget, Stockholm
Lahiri D. K., Sambamurti K. and Bennett D. A. (2004). Apolipoprotein gene and its interaction with the environmentally driven risk factors: molecular, genetic and epidemiological studies of Alzheimer’s disease. Neurobiol. Aging 25: 651–660
Lambert J. C., Wavrant-De Vrieze F., Amouyel P. and Chartier-Harlin M. C. (1998). Association at LRP gene locus with sporadic late-onset alzheimer’s disease. Lancet 351: 1787–1788
Lee J. H., Flaquer A., Stern Y., Tycko B. and Mayeux R. (2004). Genetic influences on memory performance in familial Alzheimer disease. Neurology 62: 414–421
Lopes M. B., Bogaev C. A., Gonias S. L. and VandenBerg S. R. (1994). Expression of alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein is increased in reactive and neoplastic glial cells. FEBS Lett. 338: 301–305
Mayeux R., Small S. A., Tang M., Tycko B. and Stern Y. (2001). Memory performance in healthy elderly without Alzheimer’s disease: Effects of time and apolipoprotein-E. Neurobiol. Aging 22: 683–689
McClearn G. E., Johansson B., Berg S., Pedersen N. L., Ahern F., Petrill S. A. and Plomin R. (1997). Substantial genetic influence on cognitive abilities in twins 80 or more years old. Science 276: 1560–1563
Neale M. C., Boker S. M., Xie G. and Maes H. H. (1999). Mx: Statistical Modeling. Department of Psychiatry, VCU Box 900126, Richmond, VA
Neale M. C., Cherny S. S., Sham P. C., Whitfield J. B., Heath A. C., Birley A. J. and Martin N. G. (1999). Distinguishing population stratification from genuine allelic effects with Mx: Association of ADH2 with alcohol consumption. Behav. Genet. 29: 233–243
Pedersen N. L., McClearn G. E., Plomin R., Nesselroade J. R., Berg S. and DeFaire U. (1991). The Swedish Adoption/Twin Study of Aging: An update. Acta Geneticae Medicae et Gemellologiae: Twin Res. 40: 7–20
Pedersen N. L., Plomin R., Nesselroade J. R. and McClearn G. E. (1992). A quantitative genetic analysis of cognitive abilities during the second half of the life span. Psychol. Sci. 3: 346–353
Pedersen N. L., Ripatti S., Berg S., Reynolds C., Hofer S. M., Finkel D., Gatz M. and Palmgren J. (2003). The influence of mortality on twin models of change: addressing missingness through multiple imputation. Behav. Genet. 33: 161–169
Plomin R. and Spinath F. M. (2004). Intelligence: Genetics, genes, and genomics. J. Pers. Soc. Psychol. 86: 112–129
Posthuma D., de Geus E. J., Boomsma D. I. and Neale M. C. (2004). Combined linkage and association tests in mx. Behav. Genet. 34: 179–196
Posthuma D., Neale M. C., Boomsma D. I. and de Geus E. J. C. (2001). Are smarter brains running faster? Heritability of alpha peak frequency, IQ, and their interrelation. Behav. Genet. 31: 567–579
Puglielli L., Tanzi R. E. and Kovacs D. M. (2003). Alzheimer’s disease: The cholesterol connection. Nat. Neurosci. 6: 345–351
Rebeck G. W., Harr S. D., Strickland D. K. and Hyman B. T. (1995). Multiple, diverse senile plaque-associated proteins are ligands of an apolipoprotein E receptor, the alpha 2-macroglobulin receptor/low-density-lipoprotein receptor-related protein. Ann. Neurol. 37: 211–217
Reiman E. M., Chen K., Alexander G. E., Caselli R. J., Bandy D., Osborne D., Saunders A. M. and Hardy J. (2004). Functional brain abnormalities in young adults at genetic risk for late-onset alzheimer’s dementia. PNAS 101: 284–289
Reynolds C. A., Finkel D., McArdle J. J., Gatz M., Berg S., and Pedersen N. L. (2005). Quantitative genetic analysis of latent growth curve models of cognitive abilities in adulthood. Dev. Psychol. 41: 3–16
Riley K. P., Snowdon D. A., Saunders A. M., Roses A. D., Mortimer J. A. and Nanayakkara N. (2000). Cognitive function and apolipoprotein E in very old adults: findings from the Nun Study. J. Gerontol. B Psychol. Sci. Soc. Sci. 55: S69–75
Ripatti S., Gatz M., Pedersen N. L. and Palmgren J. (2003). Three-state frailty model for age at onset of dementia and death in Swedish twins. Genet. Epidemiol. 24: 139–149
SAS. (1999). SAS online documentation for Windows (Version Release 8). SAS Institute Inc., Cary, NC
Sanchez-Guerra M., Combarros O., Infante J., Llorca J., Berciano J., Fontalba A., Fernandez-Luna J. L., Pena N. and Fernandez-Viadero C. (2001). Case-control study and meta-analysis of low density lipoprotein receptor-related protein gene exon 3 polymorphism in Alzheimer’s disease. Neurosci. Lett. 316: 17–20
Saunders A. J., Bertram L., Mullin K., Sampson A. J., Latifzai K., Basu S., Jones J., Kinney D., MacKenzie-Ingano L., Yu S., Albert M. S., Moscarillo T. J., Go R. C., Bassett S. S., Daly M. J., Laird N. M., Wang X., Velicelebi G., Wagner S. L., Becker D. K., Tanzi R. E. and Blacker D. (2003). Genetic association of Alzheimer’s disease with multiple polymorphisms in alpha-2-macroglobulin. Hum. Mol. Genet. 12: 2765–2776
Schmitt F. A., Davis D. G., Wekstein D. R., Smith C. D., Ashford J. W. and Markesbery W. R. (2000). “Preclinical” AD revisited: neuropathology of cognitively normal older adults. Neurology 55: 370–376
Small B. J., Graves A. B., McEvoy C. L., Crawford F. C., Mullan M. and Mortimer J. A. (2000). Is APOE – epsilon4 a risk factor for cognitive impairment in normal aging? Neurology 54: 2082–2088
Smith G. E., Bohac D. L., Waring S. C., Kokmen E., Tangalos E. G., Ivnik R. J. and Petersen R. C. (1998). Apolipoprotein E genotype influences cognitive ‘phenotype’ in patients with Alzheimer’s disease but not in healthy control subjects. Neurology 50: 355–362
Strittmatter W. J., Saunders A. M., Schmechel D., Pericak-Vance M., Enghild J., Salvesen G. S. and Roses A. D. (1993). Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc. Natl. Acad. Sci. USA 90: 1977–1981
Swanson H. L. (1999). What develops in working memory? A life span perspective. Dev. Psychol. 35: 986–1000
Thurstone L. L. (1948). Primary Mental Abilities. University of Chicago Press, Chicago
Warzok R. W., Kessler C., Apel G., Schwarz A., Egensperger R., Schreiber D., Herbst E. W., Wolf E., Walther R. and Walker L. C. (1998). Apolipoprotein E4 promotes incipient Alzheimer pathology in the elderly. Alzheimer Dis. Assoc. Disord. 12: 33–39
Wilson R. S., Schneider J. A., Barnes L. L., Beckett L. A., Aggarwal N. T., Cochran E. J., Berry-Kravis E., Bach J., Fox J. H., Evans D. A. and Bennett D. A. (2002). The apolipoprotein E epsilon 4 allele and decline in different cognitive systems during a 6-year period. Arch. Neurol. 59: 1154–1160
Acknowledgments
Analytical work and genotyping was supported by R01-AG17561. The Swedish Adoption/Twin Study of Aging (SATSA) is supported by R01-AG04563 and AG10175, The MacArthur Foundation Research Network on Successful Aging, and the Swedish Council for Social Research (97:0147:1B).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Reynolds, C.A., Prince, J.A., Feuk, L. et al. Longitudinal Memory Performance During Normal Aging: Twin Association Models of APOE and Other Alzheimer Candidate Genes. Behav Genet 36, 185–194 (2006). https://doi.org/10.1007/s10519-005-9027-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10519-005-9027-6